RadNet
RDNT
68.61
-1.67
-2.38%
RadNet
US · RDNT
#2019 by market cap
Listed 1970
68.61
-1.67
-2.38%
Live - 5344 symbols - heartbeat 483s ago
· 2026-10-07 19:54
After-hours
68.61
0.00%
- Market cap
- 5.40B
- P/E (TTM)i
- -263.88
- P/Bi
- 4.93
- EPSi
- -0.25
- Div yieldi
- 0.00%
- 52W posi
- 51%
Reader sentiment
Are you bullish or bearish on RDNT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership fell 0.8 percentage points.
Institutional ownership
- Held by institutions
- 104.91% -0.77pp
- Institutions
- 394 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions trimmed shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund86.03%
Hedge Fund12.05%
Individual/Insider10.26%
Public Company3.22%
Government Pension Fund1.32%
Family Office/Trust0.72%
Sovereign Wealth Fund0.70%
Private Company0.42%
Insurance Company0.29%
Top holders
BlackRock
13.92%
RTW Investments, LP
6.16%
Sandy Kaminsky
5.78%
T. Rowe Price Group, Inc.
5.72%
Vanguard Portfolio Management, LLC
5.17%
Vanguard Capital Management, LLC
4.70%
Beck, Mack & Oliver LLC
4.02%
State Street Global Advisors
3.61%
Geode Capital Management, LLC
2.36%
American Century Investment Management
2.06%
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 21 buys · 29 sells
| Name | Role | Stake |
|---|---|---|
| Alma Sorensen | Executive VP, Chief Science Officer & Director | 1.53% |
| Stephen Forthuber | President & COO of Eastern Operations | 0.64% |
| Howard Berger | Chairperson & CEO | 0.61% |
| Norman Hames | President & COO of Western Operations | 0.38% |
| David Swartz | Lead Independent Director | 0.27% |
| Mital Patel | Executive VP of Financial Planning & Analysis and Chief Administrative Officer | 0.25% |
| Lawrence Levitt | Independent Director | 0.21% |
| Ranjan Jayanathan | Executive VP, Chief Information Officer & GM of eRAD - Radiology Information Technology Division | 0.18% |
| David Katz | Executive Vice President | 0.12% |
| Cornelis Wesdorp | President & CEO of Digital Health | 0.09% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-06-17 | David Swartz | Lead Independent Director | Open Market Disposition | -2,699 | $53.89 |
| 2026-06-15 | Howard Berger | Chairperson & CEO | Other Disposition | -90 | -- |
| 2026-06-15 | Cornelis Wesdorp | President & CEO of Digital Health | Open Market Disposition | -4,750 | $58.11 |
| 2026-06-14 | Stephen Forthuber | President & COO of Eastern Operations | Open Market Disposition | -44,067 | $57.79–58.61 |
| 2026-06-01 | David Swartz | Lead Independent Director | Other Acquisition | +2,946 | -- |
| 2026-06-01 | Gregory Spurlock | Independent Director | Other Acquisition | +2,946 | -- |
| 2026-06-01 | Lawrence Levitt | Independent Director | Other Acquisition | +2,946 | -- |
| 2026-06-01 | Laura Jacobs | Independent Director | Other Acquisition | +2,946 | -- |
| 2026-05-04 | Howard Berger | Chairperson & CEO | Derivative Exercise and Retained | +25,992 | $18.64 |
| 2026-03-18 | Alma Sorensen | Executive VP, Chief Science Officer & Director | Other Disposition | -7,000 | -- |
| 2026-03-18 | Alma Sorensen | Executive VP, Chief Science Officer & Director | Open Market Disposition | -15,000 | $61.84–63.59 |
| 2026-03-17 | Alma Sorensen | Executive VP, Chief Science Officer & Director | Open Market Disposition | -15,000 | $62.12–62.72 |
| 2026-03-15 | Alma Sorensen | Executive VP, Chief Science Officer & Director | Sale to Issuer | -5,919 | $61.72 |
| 2026-03-09 | Alma Sorensen | Executive VP, Chief Science Officer & Director | Derivative Exercise and Retained | +62,964 | -- |
| 2026-03-02 | Howard Berger | Chairperson & CEO | Other Acquisition | +124,001 | -- |
| 2026-03-02 | Norman Hames | President & COO of Western Operations | Other Acquisition | +25,145 | -- |
| 2026-03-02 | Mark Stolper | Chief Financial Officer | Other Acquisition | +18,228 | -- |
| 2026-03-02 | Michael Murdock | Executive Vice President of Mergers & Acquisitions | Other Acquisition | +6,613 | -- |
| 2026-03-02 | Stephen Forthuber | President & COO of Eastern Operations | Other Acquisition | +22,045 | -- |
| 2026-03-02 | Cornelis Wesdorp | President & CEO of Digital Health | Other Acquisition | +20,330 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.